Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
scientific article published on 01 October 2020
Author/s
author: Alessio Cortellini, Alessandro Morabito, Corrado Ficorella, Giampiero Porzio, Mariangela Torniai, Olga Nigro, Raffaele Giusti, Biagio Ricciuti, Sebastiano Buti, Fausto Petrelli
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.